What is the current price and volume for ALNEV.PA stock?

ALNEV.PA stock trades at **€0.0034** in pre-market on 28 Jan 2026 with **volume 18,242,498** and average volume **4,727,276**, indicating a strong intraday interest and elevated liquidity risk.

What grade does Meyka AI give ALNEV.PA stock and why?

Meyka AI rates ALNEV.PA **58.12 (C+) — HOLD**. The grade balances Neovacs’ pipeline potential with weak cash flow, negative EPS, low liquidity, and limited recent corporate updates.

What is Meyka AI's price forecast for ALNEV.PA stock?

Meyka AI's forecast model projects **€0.0050** short-term for ALNEV.PA stock, implying an upside of **47.06%** from **€0.0034**. Forecasts are model-based projections and not guarantees.

What are the main risks for ALNEV.PA stock investors?

Primary risks for ALNEV.PA stock are continued negative cash flow, potential dilution to fund trials, thin free float that magnifies moves, and lack of recent earnings updates since 2019.

EU Stocks

ALNEV.PA Neovacs S.A. (EURONEXT) pre-market 28 Jan 2026: €0.0034, most-active by volume

ByDanny Kontos January 28, 2026January 28, 2026

ALNEV.PA stock leads pre-market activity on EURONEXT on 28 Jan 2026 after 18,242,498 shares traded, signaling unusually high trader interest. At €0.0034, Neovacs S.A. (ALNEV.PA) is down -2.86% on the day but shows a relative volume of 3.87x versus its 50-day average. This note separates short-term trading drivers from longer-term fundamentals and sets the stage for price targets and risk factors ahead of the open.